Journal
BREAST CANCER RESEARCH
Volume 13, Issue 3, Pages -Publisher
BMC
DOI: 10.1186/bcr2890
Keywords
-
Categories
Funding
- Breakthrough Breast Cancer
- Cancer Research UK
- Val d'Aurelle Anticancer Centre (Montpellier, France)
Ask authors/readers for more resources
Breast cancer comprises a collection of diseases with distinctive clinical, histopathological, and molecular features. Importantly, tumors with similar histological features may display disparate clinical behaviors. Gene expression profiling using microarray technologies has improved our understanding of breast cancer biology and has led to the development of a breast cancer molecular taxonomy and of multigene 'signatures' to predict outcome and response to systemic therapies. The use of these prognostic and predictive signatures in routine clinical decision-making remains controversial. Here, we review the clinical relevance of microarray-based profiling of breast cancer and discuss its impact on patient management.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available